Clinical response to a MEK inhibitor in a patient with metastatic melanoma harboring an RAF1 gene rearrangement detected by cancer gene panel testing.
Kenta NakamaDai OgataEiji NakanoKeita TsutsuiShunichi JinnaiKenjiro NamikawaAkira TakahashiNaoya YamazakiPublished in: The Journal of dermatology (2021)